Immunogen reported $121.86M in Current Liabilities for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Agios Pharmaceuticals AGIO:US USD 62.63M 9.03M
Amgen AMGN:US USD 15.69B 1.36B
Astellas Pharma 4503:JP JPY 705.91B 55.51B
AstraZeneca AZN:LN USD 26.29B 1.44B
Bluebird Bio BLUE:US USD 126.73M 22.13M
Emergent Biosolutions EBS:US USD 1.23B 961.5M
Exelixis EXEL:US USD 324.36M 22.63M
Halozyme Therapeutics HALO:US USD 130.79M 21.4M
Heron Therapeutics HRTX:US USD 93.88M 15.62M
Immunogen IMGN:US USD 121.86M 18.22M
Intrexon XON:US USD 78.64M 26.22M
Karyopharm Therapeutics KPTI:US USD 72M 10.24M
Macrogenics MGNX:US USD 48.61M 1.43M
Nektar Therapeutics NKTR:US USD 68.2M 15.78M
Novartis NVS:US USD 28.66B 496M
Regeneron Pharmaceuticals REGN:US USD 3.85B 969.9M
Roche Holding ROG:VX 27.24B 170M
Seattle Genetics SGEN:US USD 818.4M 92.41M